All Stories

  1. Serological Evidence and Self-reported Outcomes in Patients with Adrenal Insufficiency during the First Waves of COVID-19 in North-East Italy
  2. Corrigendum to: Understanding and managing interferences in clinical laboratory assays: the role of laboratory professionals
  3. Automated Mindray CL-1200i chemiluminescent assays of renin and aldosterone for the diagnosis of primary aldosteronism
  4. Home pregnancy tests: quality first
  5. SARS-CoV-2 antibody performances: we need better criteria
  6. SARS-CoV-2 serosurvey in health care workers of the Veneto Region
  7. Evaluation of an ELISA for SARS-CoV-2 antibody testing: clinical performances and correlation with plaque reduction neutralization titer
  8. Towards the rational utilization of SARS-CoV-2 serological tests in clinical practice
  9. SARS-CoV-2 RNA identification in nasopharyngeal swabs: issues in pre-analytics
  10. Erythrocyte sedimentation rate is associated with severe coronavirus disease 2019 (COVID-19): a pooled analysis
  11. Molecular diagnostics at the times of SARS-CoV-2 outbreak
  12. Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics
  13. Quality controls for serology: an unfinished agenda
  14. Clinical laboratory and SARS-CoV-2 infection: where do we stand?
  15. New insights on the analytical performances for detecting and quantifying monoclonal proteins
  16. Measurement uncertainty: light in the shadows
  17. Understanding and managing interferences in clinical laboratory assays: the role of laboratory professionals
  18. Reflex TSH strategy: the good, the bad and the ugly
  19. Total testing process: roots and state-of-the-art
  20. Serum or plasma? An old question looking for new answers
  21. CCLM Award for the Most Cited Paper
  22. Blood biomarkers in neurology: “a call to arms” for laboratory professionals
  23. Professor Howard A. Morris
  24. The silk road to total quality in Laboratory Medicine
  25. Jillian Russyll (AKA Jill) Tate
  26. A pilot study for establishing quality indicators in molecular diagnostics according to the IFCC WG-LEPS initiative: preliminary findings in China
  27. System-related and cognitive errors in laboratory medicine
  28. Cigarette Smoking is Associated with Decreased Bone Gla-protein (BGP) Levels in Hemodialysis Patients
  29. Norbert Tietz, 13th November 1926–23rd May 2018
  30. Harmonization in laboratory medicine: Blowin’ in the wind
  31. Warfarin, but not rivaroxaban, promotes the calcification of the aortic valve in ApoE−/− mice
  32. Clinical laboratory: bigger is not always better
  33. Quality and future of clinical laboratories: the Vico’s whole cyclical theory of the recurring cycles
  34. Extra-analytical quality indicators – where to now?
  35. Laboratory-related errors: you cannot manage what you don’t measure. You manage what you know and measure
  36. Harmonization in laboratory medicine: more than clinical chemistry?
  37. Clinical Laboratory Medicine: An Alliance for the Optimal Management of Acute Kidney Injury with the Use of Biomarkers
  38. Massive Troponin Release and Normal Coronary Arteries: Where Does the Truth Lie?
  39. Analytical quality: an unfinished journey
  40. Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents
  41. Biomarkers of acute kidney injury: a step forward
  42. Diagnostic and prognostic value of low percentage of glycosylated ferritin in acquired hemophagocytic lymphohistiocytosis: A single-center study
  43. Biological variation of serum creatinine
  44. Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH-dependent Cushing's syndrome
  45. High sensitivity cardiac troponin T in patients not having an acute coronary syndrome: results from the TRAPID-AMI study
  46. Quantitative Value of Aldosterone‐Renin Ratio for Detection of Aldosterone‐Producing Adenoma: The Aldosterone‐Renin Ratio for Primary Aldosteronism (AQUARR) Study
  47. Biological Variation Estimates Obtained from 91 Healthy Study Participants for 9 Enzymes in Serum
  48. Impaired Release of Vitamin D in Dysfunctional Adipose Tissue: New Cues on Vitamin D Supplementation in Obesity
  49. A note from the Editor in Chief regarding the Letter to the Editor “Great need for changes in higher education in Greece”
  50. A real-world evidence-based approach to laboratory reorganization using e-Valuate benchmarking data
  51. Quality Indicators in Laboratory Medicine: the status of the progress of IFCC Working Group “Laboratory Errors and Patient Safety” project
  52. ISO 15189 Accreditation: Navigation Between Quality Management and Patient Safety
  53. Mass spectrometry or immunoassay: est modus in rebus
  54. Serial Sampling of High-Sensitivity Cardiac Troponin T May Not Be Required for Prediction of Acute Myocardial Infarction Diagnosis in Chest Pain Patients with Highly Abnormal Concentrations at Presentation
  55. Healthcare is a giant with feet of clay
  56. A Case of Atypical Urticaria
  57. Performance criteria and quality indicators for the post-analytical phase
  58. The quality indicator paradox
  59. Improving diagnosis and reducing diagnostic errors: the next frontier of laboratory medicine
  60. In Memoriam: Gérard Siest (1936–2016)
  61. The Choosing Wisely campaign – don’t throw the baby out with the bathwater
  62. The use of extra-analytical phase quality indicators by clinical laboratories: the results of an international survey
  63. CCLM Award for the Most Cited Paper Recently Published
  64. Towards a new paradigm in laboratory medicine: the five rights
  65. Corrigendum to: Performance criteria and quality indicators for the pre-analytical phase
  66. The standardization of the urine albumin assays: no longer deferrable
  67. Biological variation: back to basics
  68. Procalcitonin-guided antibiotic therapy: a potentially effective and efficient strategy
  69. Performance criteria and quality indicators for the pre-analytical phase
  70. Clinical laboratories: production industry or medical services?
  71. Evaluating and using innovative technologies: a lesson from Theranos?
  72. A new integrated tool for assessing and monitoring test comparability and stability
  73. Once upon a time: a tale of ISO 15189 accreditation
  74. Can biomarkers help us to better diagnose and manage sepsis?
  75. Asymmetric Dimethylarginine, Race, and Mortality in Hemodialysis Patients
  76. Appropriate labelling of blood collection tubes: a step ahead towards patient’s safety